Mani Mohindru - CFO & Chief Strategy Officer, Cara Therapeutics, Inc

As of December 4, 2019


Mani Mohindru Net Worth

  • Net worth is estimated to be at least $2.14M
  • Owns at least 17,441 units of Cara Therapeutics, Inc stock
  • Sold an estimated value of $2.05M in the last 2 years at Cara Therapeutics, Inc

Mani Mohindru Trading

  • Largest purchase of shares was 37,431 units , worth over $526.28K on July 17, 2019
  • Largest sale of shares was 37,431 units , worth over $935.77K on July 17, 2019
  • In total has made about 10 transactions over 2 years
  • Usually trades in March and December, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Mani Mohindru Mailing Address

  • Mailing address is C/o Cara Therapeutics, Inc. 4 Stamford Plaza, 107 Elm Street Stamford CT 06902 CT

Cara Therapeutics, Inc Insider Trading

  • The most recent transaction was 1,642 units sold on April 5, 2022 by Scott Terrillion worth over $19.56K
  • In the last 8 years, insiders at Cara Therapeutics, Inc sold an estimated value of $26.43M and bought an estimated value of $21.23M
  • The most active traders are Phd Frederique Menzaghi, Chief Scientific OffSVP-R&D,  Derek Chalmers, President & CEO,  and Joana Goncalves, Chief Medical Officer
  • Insider trading is most common in June, with the busiest year in 2020

Cara Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1